Sulukast
Alternative Names: LY 170680Latest Information Update: 11 Nov 1994
At a glance
- Originator Eli Lilly and Company
- Class Antiasthmatics
- Mechanism of Action Leukotriene E4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Asthma